Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer.
Nat Cell Biol. 2021 Sep;23(9):1023-1034. doi: 10.1038/s41556-021-00743-5. Epub 2021 Sep 6.
Nat Cell Biol. 2021.
PMID: 34489572
Free PMC article.
ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer.
Tabrizian N, Nouruzi S, Cui CJ, Kobelev M, Namekawa T, Lodhia I, Talal A, Sivak O, Ganguli D, Zoubeidi A.
Tabrizian N, et al. Among authors: nouruzi s.
Cell Rep. 2023 Aug 29;42(8):112937. doi: 10.1016/j.celrep.2023.112937. Epub 2023 Aug 7.
Cell Rep. 2023.
PMID: 37552603
Free article.
Item in Clipboard
ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer.
Nouruzi S, Ganguli D, Tabrizian N, Kobelev M, Sivak O, Namekawa T, Thaper D, Baca SC, Freedman ML, Aguda A, Davies A, Zoubeidi A.
Nouruzi S, et al.
Nat Commun. 2022 Apr 27;13(1):2282. doi: 10.1038/s41467-022-29963-5.
Nat Commun. 2022.
PMID: 35477723
Free PMC article.
Item in Clipboard
Beyond Expression: Role of Phosphorylated Residues of EZH2 in Lineage Plasticity in Prostate Cancer.
Nouruzi S, Tabrizian N, Zoubeidi A.
Nouruzi S, et al.
Endocrinology. 2023 Feb 11;164(4):bqad023. doi: 10.1210/endocr/bqad023.
Endocrinology. 2023.
PMID: 36718085
Review.
Item in Clipboard
Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer.
Thaper D, Vahid S, Kaur R, Kumar S, Nouruzi S, Bishop JL, Johansson M, Zoubeidi A.
Thaper D, et al. Among authors: nouruzi s.
Sci Rep. 2018 Nov 23;8(1):17307. doi: 10.1038/s41598-018-35612-z.
Sci Rep. 2018.
PMID: 30470788
Free PMC article.
Item in Clipboard
Cite
Cite